As a result, stimulation of the ABCA1/apoA-I pathway can decrease the lipid levels in hepatocytes, which in turn causes a decrease in ER stress levels as well as the expression levels of lipogenic genes, eventually resulting in a reduction in hepatic steatosis. This evidence concerns the gene APOA1 and fatty liver disease.